Application of the nonlinear Blinder-Oaxaca decomposition to study racial/ethnic disparities in antiobesity medication use in the United States

Research in Social & Administrative Pharmacy : RSAP
Hemalkumar B MehtaMichael L Johnson

Abstract

The nonlinear Blinder-Oaxaca (BO) decomposition method is gaining popularity in health services research because of its ability to explain disparity issues. The present study demonstrates the use of this method for categorical variables by addressing antiobesity medication use disparity. To examine racial/ethnic disparity in antiobesity medication use and to quantify the observed factor contribution behind the disparity using the nonlinear BO decomposition. Medical Expenditure Panel Survey data, 2002-2007, were used in this retrospective cross-sectional study. Adults with body mass index (BMI) >30, or BMI ≥27 and comorbidities such as hypertension, cardiovascular diseases, diabetes, or hyperlipidemia were included in the cohort (N=65,886,625). Multivariable logistic regression was performed to examine racial/ethnic disparity in antiobesity medication use controlling for predisposing, enabling, and need factors. The nonlinear BO decomposition was used to identify the contribution of each predisposing, enabling, and need factors in explaining the racial/ethnic disparity and to estimate the residual unexplained disparity. Non-Hispanic Blacks were 46% (odds ratio [OR]: 0.54; 95% confidence interval [CI]: 0.35-0.83) less likely to u...Continue Reading

References

Mar 1, 1995·Journal of Health and Social Behavior·R M Andersen
Feb 22, 2001·Annals of Internal Medicine·L K KhanD F Williamson
Aug 31, 2001·JAMA : the Journal of the American Medical Association·H M BlanckM K Serdula
Apr 21, 2006·Medical Care·James B KirbySamuel H Zuvekas
Feb 28, 2007·Journal of the American Dietetic Association·Heidi Michels BlanckBarbara E Ainsworth
Apr 5, 2007·Journal of General Internal Medicine·Rachel A ElliottStephen B Soumerai
Aug 7, 2008·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·UNKNOWN Counterweight Project Team
Sep 17, 2008·Research in Social & Administrative Pharmacy : RSAP·Junling WangShelley I White-Means
Mar 21, 2009·Obesity·Ed J HendricksFrank L Greenway
Oct 27, 2009·Journal of General Internal Medicine·Arturo Vargas BustamanteAlexander N Ortega
Feb 2, 2010·The Annals of Pharmacotherapy·Jie ChenAlexander N Ortega
Mar 9, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Elizabeth A Hall-Lipsy, Marie A Chisholm-Burns
Mar 23, 2010·Patient Education and Counseling·Sara N BleichLisa A Cooper
Jan 22, 2011·Obesity·Daniel J Dutton, Lindsay McLaren
May 5, 2011·American Journal of Epidemiology·Mohammad Hassan EmamianAkbar Fotouhi

❮ Previous
Next ❯

Citations

Apr 23, 2015·Vaccine·Byung-Kwang YooPeter G Szilagyi
Oct 24, 2017·Epidemiology and Health·Ebrahim RahimiHamid Soori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Revista da Associação Médica Brasileira
Maria do Carmo de Carvalho e MartinsIúri Paz Lima
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Xiao-Ying WuLing He
Archives of Internal Medicine
Randall S Stafford, David C Radley
Pharmacotherapy
Christian HamppVicky Borders-Hemphill
© 2021 Meta ULC. All rights reserved